SOL Capital Management CO Sells 5,425 Shares of SPDR S&P Biotech ETF $XBI

SOL Capital Management CO lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,565 shares of the exchange traded fund’s stock after selling 5,425 shares during the period. SOL Capital Management CO’s holdings in SPDR S&P Biotech ETF were worth $1,660,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of XBI. Prime Capital Investment Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF by 37.9% in the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock worth $824,000 after purchasing an additional 2,729 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 574.5% during the 2nd quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after buying an additional 6,032 shares in the last quarter. Brian Low Financial Group LLC purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $668,000. Altfest L J & Co. Inc. increased its stake in SPDR S&P Biotech ETF by 63.1% in the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after acquiring an additional 48,326 shares during the last quarter. Finally, Investment Partners Asset Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 4.0% during the 2nd quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after acquiring an additional 125 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $124.18 on Friday. The firm has a fifty day moving average price of $121.14 and a 200 day moving average price of $104.39. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $129.12. The firm has a market cap of $8.22 billion, a PE ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.